Narrative review highlights clinical benefits and technical limitations of 5-ALA in glioblastoma surgery, suggesting further integration with imaging techniques.
Aims: Glioblastoma is the most aggressive primary brain tumor, characterized by rapid proliferation and diffuse infiltration into surrounding brain tissue. Maximal safe resection is a critical prognostic factor, yet complete tumor removal remains difficult. This review aims to synthesize current data on the application of 5-aminolevulinic acid (5-ALA) in glioma surgery, with particular emphasis on its mechanism of action, clinical utility, limitations, and integration with other intraoperative imaging techniques. Methods: A narrative review was conducted using the PubMed and Google Scholar databases. The search included combinations of keywords such as "5-ALA," "5-aminolevulinic acid," "glioblastoma," "high-grade glioma," and "neurosurgery." Peer-reviewed English-language articles were selected to examine the clinical and technical aspects of 5-ALA-guided fluorescence imaging in glioma resection. No time restriction or formal inclusion criteria were applied. Results: 5-ALA induces selective fluorescence in malignant glioma tissue, enabling improved intraoperative visualization and facilitating gross total resection. Studies have demonstrated enhanced surgical outcomes, including prolonged progression-free and overall survival in patients undergoing 5-ALA-guided resection. However, limitations include reduced sensitivity in low-grade gliomas, the risk of false-positive or false-negative signals, and dependency on specialized equipment and optical conditions. Adjunctive use with intraoperative MRI and sodium fluorescein has shown preliminary benefits. Off-label applications in non-glioma tumors are under investigation. Conclusions: 5-ALA represents a clinically validated tool for improving tumor delineation and surgical precision in high-grade glioma surgery. Despite certain limitations, especially in low-fluorescence tumors and deep-seated lesions, future research into combined imaging strategies, enhanced metabolic targeting, and photodynamic applications may broaden its clinical utility.
No takes yet. Share an insight, caveat, or question.
Giba et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: